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Cell proliferationRibosomal protein L34 (RPL34) was reported to be involved in the regulation of cell proliferation of prokaryotes,
plant and animal cells. In the present study, we analyze the expression and function of RPL34 in NSCLC. Immuno-
histochemical analysis, qPCR andWestern blot were used to detect the expression of RPL34 in NSCLC tissues and
cells lines. Flow cytometry was used to detect cell activity of NSCLC cell line H1299 under lentivirus-mediated
RNAi on RPL34. Cell proliferation and colony formation assays were used to analyze the role of RPL34 in NSCLC
cell proliferation. We found that expression of ribosomal protein RPL34 was signiﬁcantly up-regulated in
NSCLC tissues compared to adjacent normal tissues. Lentivirus-mediated shRNA knockdown of RPL34 in NSCLC
cell line H1299 resulted in a strong decrease of proliferation, and amoderate but signiﬁcant increase of apoptosis
and S-phase arrest. These data indicate that over-expressed RPL34 may promote malignant proliferation of
NSCLC cells, thus playing an important role in development and progress of NSCLC.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Mammalian ribosomes are constituted of a 60S large subunit and a
40S small subunit, in which main components are ribosomal RNA
(rRNA) and ribosomal proteins. Ribosomal proteins are named as RPL (ri-
bosomal proteins in large subunit) or RPS (ribosomal proteins in small
subunit) according to the size of subunits they derived from. The main
function of ribosomal proteins is participating in the self-assembly of ri-
bosomes and protein synthesis. Recently, ribosomal proteinswere found
to be involved in other cell functions besides ribosomal functions, includ-
ing regulation of cell cycle (Nosrati et al., 2015; Gou et al., 2010) and even
malignant transformation of normal cells (Wang et al., 2011). Some ribo-
somal proteins were found to play important roles in the development
and progress of cancer cells (Khalaileh et al., 2013; Donati et al., 2011).
Ribosomal proteins play diverse roles in cancer cells. RPL6 (Du et al.,
2005), RPL13 (Kobayashi et al., 2006), RPS13 (Guo et al., 2011) and
RPL15 (Hsu et al., 2011;Wang et al., 2006;Wang et al., 2001)were high-
ly expressed in gastrointestinal cancers, increased proliferation of can-
cer cells and played an important role in development and malignance
of cancer. In gastric cancer cell line, RPL6 promoted cell cycle and cancerribosomal proteins in large sub-
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. This is an open access article undercell proliferation by up-regulating the expression of Cyclin E (Gou et al.,
2010). RPS13 promoted the growth of gastric cancer cells by down-
regulating the expression of p27 (Kip1) (Guo et al., 2011). Phosphorylat-
ed RPS3 activated anti-apoptotic protein TRAF2 and enhanced
chemoresistance in non-small cell lung cancer cells (Yang et al., 2013).
RPS3 could be secreted into extracellular in homodimers. And the secre-
tion was positively correlative with degree of drug-resistance and ma-
lignance of cancer cells (Kim et al., 2013). RPL19 was highly expressed
in some prostate cancers and colorectal cancers, and it was studied as
a prognostic biomarker for these two cancers (Bee et al., 2011; Yang
et al., 2010; Huang et al., 2008; Bee et al., 2006). In addition, RPS15A
(Xu et al., 2013), RPL26 and RPL29 (Li et al., 2012) were also found to
be associatedwith cancer cells proliferation.On the contrary, expression
of some ribosomal proteinswas down-regulated in cancers, for example
RPS8, RPS12, RPS18, RPS24, RPL13a, RPL18, RPL28, RPL32 and RPL35
(Kasai et al., 2003). Some of these ribosomal proteins acted as suppres-
sors of cancer. Down-regulation of these ribosomal proteins promotes
cancer development.
RPL34 which is constituted by 110 amino acids is a conserved ribo-
somal protein from Archaea to eukaryotes. The protein folding pattern
of RPL34 is different from most of the other ribosomal proteins. There
is a zinc ﬁnger motif binding a zinc ion in RPL34 (Klinge et al., 2011),
which suggests the distinction of RPL34. Besides the role as a
ribosome-constituting protein, RPL34 was reported to involve in other
cell functions. Devitt and Stafstrom (1995) reported that accumulationthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Over-expression of RPL34 in NSCLC cancer tissue compared to adjacent tissue. (A) RPL34 expression in 9 pairs of liquid-nitrogen-frozen tissue samples. (B) Representative immu-
nohistochemical staining of RPL34 in adjacent and cancer tissues from 32 patients. Brown staining tumor cells are RPL34 positive (magniﬁcation: 200×). (C) Representative immunohis-
tochemical staining of RPL34 in adjacent and cancer tissues from 32 patients. Brown staining tumor cells are RPL34 positive (magniﬁcation: 400×). **Signiﬁcant difference (p b 0.01).
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Table 1
The expression pattern of RPL34 in NSCLC samples revealed in immunohistochemistry
analysis.
Staining gradea
Cancer tissue Adjacent tissue
Cases Percentage Cases Percentage
b5% 3 9.38% 21 65.63%
5%–25% 6 18.75% 8 25.00%
26%–50% 10 31.25% 2 6.25%
51%–75% 8 25.00% 1 3.13%
75%–100% 5 15.63% 0 0.00%
a Sampleswere deﬁned as “RPL34 positive”when the proportion of tumor cells positive
for RPL34 (staining rate) was more than 50%.
423S. Yang et al. / Gene 576 (2016) 421–428of RPL34 mRNA was correlated with cell proliferation and RPL34 might
involve in cell cycle regulation during growth-dormancy cycles in pea
axillary buds. Dai et al. (1996) found that expression of rpl34 was
much higher in actively growing tissues than that in normal tissues of
tobacco leaf, which indicated that RPL34 was involved in cell prolifera-
tion in plant tissues. Moorthamer and Chaudhuri (1999) found that
RPL34 bound and inactivated cyclin-dependent kinase Cdk4 and Cdk5
in Hela cell. In addition, it's reported (Panagiotidis et al., 1995) that
RPL34 regulated biosynthesis of polyamines in Escherichia coli. On
the other hand, elevated levels of intracellular polyamines up-
regulated the expression of RPL34. As small biomolecules with positive
charge, polyamines were associated with chromatin stability, geneFig. 2. Lentivirus-mediated RPL34 shRNA signiﬁcantly suppressed the expression of RPL34. (A)
ﬂuorescence indicated lentivirus infection. (B) mRNA level of RPL34 in H1299was signiﬁcantly
lentivirus infected group (control). (C) Western bolt signal of RPL34 by anti-RPL34 antibody in
(control). The relative expression level of RPL34was shown in theﬁgure, whichwas detected by
(p b 0.01).transcription and protein translation. Therefore, RPL34 may play roles
as mediator in the feedback regulation between polyamines and cell
functions. In conclusion, RPL34 was reported to be involved in cell pro-
liferation in prokaryotes, plant and animal cells.
So far, there is no report about the role of RPL34 in NSCLC. In the
present study, we showed for the ﬁrst time that over-expressed RPL34
promotes malignant proliferation and apoptosis-resistance in NSCLC
cells.
2. Methods
2.1. Cell lines, reagents and antibodies
Human NSCLC cell lines H1299 and embryonic kidney cell line 293 T
were purchased from the American Type Culture Collection (ATCC,
USA) and cultured either in DMEMmedium (293 T) or RPMI-1640 me-
dium(H1299) containing 10% fetal bovine serum, 100 μg/ml streptomy-
cin and 100 IU/ml penicillin at 37 °Cwith 5%CO2 and 95%humidity.MTT
was purchased from Genview (Cat. No. JT343). Rabbit RPL34 polyclonal
antibody used for immunohistochemical assay and Western blot was
purchased from Abcam (Cat No.ab129394). Mouse anti-Bcl-2 mAb
was purchased from Abcam (Cat No. ab117115). Anti-GAPDH mAb
was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Annexin V­APC apoptosis detection kit was purchased from eBioscience
(San Diego, CA, USA).The infected efﬁciency of control lentivirus and Lv-shRPL34 in H1299. Cell showed green
down-regulated in Lv-shRPL34 infected group (RPL34 shRNA) compared to control shRNA
H1299 transfected by Lv-shRPL34 (RPL34 shRNA) or lentivirus mediated control shRNA
gray value analysis of thewestern-blot strips. ** Signiﬁcant difference from control groups
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Sequences of RPL34 shRNAwere inserted into the pGCSIL-GFP lenti-
virus shRNA expression system (Genechem). The shRNA containing
vectors were co-transfected together into 293 T cells with pHelper1.0
and lentiviral helper plasmid pHelper2.0 using Lipofectamine 2000
(Invitrogen) to generate the respective lentiviruses. Viral stocks collect-
ed from 293 T cells were used to infect H1299 cells. The RNAi target of
RPL34 was: TGCTGTAAGACCTAAAGTT. The sequence inserted into
pGCSIL-GFP to form RPL34 shRNA was: CCGGGACCTAAAGTTCTTATGA
GATTTCAAGAGAATCTCATAAGAACTTTAGGTCTTTTTG. The mRNA and
protein levels were measured at 72 h after cells being infected.2.3. qPCR analysis
Total RNAwas isolatedwith TRIzol reagent (Invitrogen, USA) and re-
verse transcribed with PrimeScript® RT reagent Kit (Takara, Japan).
cDNA was normalized with GAPDH. Real-time PCR was performed by
three-step methods using SYBR® Premix Ex TaqTM II kit (Takata,
Japan) with 55 °C annealing temperature and 40 ampliﬁcation cycles.
Individual test was carried out in triplicate. GAPDHwas used as internal
control. The relative amount of each cDNA were analyzed by means of
2−△△Ct. Primers for real-time PCR for RPL34 and GAPDHwere as follow:
RPL34-F:GTTTGACATACCGACGTAGGC,RPL34-R:GCACACATGGAACCAC
CATAG;GAPDH-F:TGACTTCAACAGCGACACCCA,GAPDH-R:CACCCTGTTG
CTGTAGCCAAA.Fig. 3. Down-regulation of RPL34 inhibits proliferation of NSCLC cells H1299. (A) Pictures of len
ferent times after transfection. (B) Cell growthwasmeasured bymultiparametric high content s
regulated.(C) MTT assay showed that proliferation of H1299 was signiﬁcantly inhibited when2.4. Western blot
Western blot was done to detect the expression of RPL34 in H1299.
20 μg of protein samples prepared from H1299 transfected with RPL34
shRNA lentivirus or control shRNA lentivirus was subjected to SDS-
PAGE, transferred to PVDF membranes (Millipore, Kankakee, IL, USA)
and detectedwith rabbit anti-RPL34 (1:500, Abcam) followed by horse-
radish peroxidase conjugated goat anti-rabbit IgG (1:5000, Santa Cruz).
Western blot of Bcl-2 was detected by mouse mAb (1:5000, Abcam)
followed by horseradish peroxidase conjugated anti-mouse IgG
(1:5000, Santa Cruz). GAPDH, chosen as internal control, was detected
with mouse anti-GAPDH (1:5000, Santa Cruz). The protein signals
were detected using SuperSignal™ West Dura Extended Duration
Substrate (Pierce, Rockford, IL, USA) and analyzed in Tanon GIS 1D
(Shanghai, China) software. All densitometric values were normalized
against the relative GAPDH value.2.5. Colony formation assay
Cells were seeded into six-well plates (200 cells/well) (in
three duplicate wells) and cultured at 37 °C in 5% CO2. After two
weeks, the cells were ﬁxed with paraformaldehyde for 30 min and
then stained with GIEMSA for 10 min. ddH2O was used to wash the
cells three times to obtain a clean background. The number of colonies
and the cell number in each colony were counted and statistically
analyzed.tivirus transfection of nonsense shRNA (control) and RPL34 shRNA (RPL34 shRNA) in dif-
creening (HCS). Proliferation of H1299was signiﬁcantly inhibitedwhen RPL34was down-
RPL34 was down-regulated.
Fig. 4. Down-regulation of RPL34 inhibits colony formation of NSCLC cells H1299.
(A) Colony formation of H1299 infected with control lentivirus (control) and Lv-
shRPL34 (RPL34 shRNA) in a 6-well plate 2 weeks after seeded. (B) Representative colony
of H1299 infected with control lentivirus (control) and Lv-shRPL34 (RPL34 shRNA)
2 weeks after seeded. (C) Clone number per well shown in histogram. Results were
shown as mean ± S.D.* Signiﬁcant difference from control groups (p b 0.05).
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Tissue sections (5-μm thick) were dewaxed, followed by quenching
the endogenous peroxidase with 3% H2O2 in methanol for 30min. Prior
to staining, non-speciﬁc binding was blocked by incubation with 10%
BSA in PBS at 37 °C for 1 h. Tissue sections were incubated with speciﬁc
antibodies in PBS containing 1% BSA at 4 °C overnight, followed by incu-
bation with a horseradish peroxidase-conjugated anti-mouse or rabbit
antibody. Color was then developed by incubation with an Immuno
Pure Metal Enhanced Diaminobenzidine (DAB) Substrate kit (Pierce).
After incubation, tissue sections were washed three times with PBS for
10 min. Tissue sections were ﬁnally counterstained with hematoxylin.
For determination of RPL34, cytosolic staining of yellowish or brownish
granules was graded as follows: 0 for background staining, 1 for faint
staining, 2 for moderate staining and 3 for strong staining. In addition,
positive staining areas in entire tissue section were graded as follows:
0 for b5%, 1 for 5–25%, 2 for 26–50%, 3 for 51–75%, and 4 for 76%–
100%. Combining these two parameters, 0–2 and ≥ 3 were considered
negative and positive staining respectively.
2.7. Flow cytometric analysis
Cells were harvested by centrifugation at 1200 rpm for 5 min after
7 days of infection. The pellets were washed twice with cold PBS, ﬁxed
with chilled 70% ethanol, centrifuged at 1500 rpm for 5 min to discard
ethanol and re-suspended with PBS sequentially. The suspensions
were ﬁltrated through a 38 μm pore membrane and centrifuged at
1200 rpm for 5 min. The cells were stained with propidium iodide (PI)
or Annexin V at 4 °C for 30 min in dark for ﬂow cytometric analysis.
Each experiment was conducted in triplicate.
2.8. Cell proliferation assay
Cell growthwasmeasured viamultiparametric high content screen-
ing (HCS). Brieﬂy, H1299 cells at 10 days after infection with either
control or RPL34 shRNA lentivirus were seeded at 2000 cells per well
in 96-well plates, incubated at 37 °C with 5% CO2 for 5 days. Plates
were scannedwith ArrayScan™HCS (Cellomics Inc.) every day. The sys-
tem is a computerized, automated ﬂuorescence-imaging microscope
that automatically identiﬁes stained cells. MTT assay was conducted as
below. H1299 cells at 10 days after infection with either control or
RPL34 shRNA lentivirus were seeded at 2000 cells per well in 96-well
plates, then incubated at 37 °C with 5% CO2 for 5 days. 5 wells each
group were added in MTT and incubated for 4 h at 37 °C with 5% CO2.
Then standard procedure was conducted as described by the manufac-
turer and OD value was tested at a wavelength of 490 nm (Tecan
inﬁnite).
2.9. Statistical analysis
One-way ANOVA and Student's t-test were used for raw data analy-
sis. Statistical analysis was performed using SPSS12.0 software package.
All values in the text and ﬁgures are expressed as mean ± s.d. p b 0.05
was considered as statistically signiﬁcant.
3. Results
3.1. Up-regulated expression of RPL34 in NSCLC
RPL34 expression in 9 pairs of liquid-nitrogen-frozen tissue samples
(NSCLC tissues and adjacent normal tissue) from 9 patients was detect-
ed with qPCR. As shown in Fig. 1A, RPL34 expression inmRNA level was
3.25 times in NSCLC tissue (with a meanmRNA expression level of 2.8)
of that in adjacent normal tissue (with ameanmRNAexpression level of
0.86).The results showed that RPL34 was over-expressed in NSCLC cells
in mRNA level. To study the expression of RPL34 in NSCLC cells inprotein level, immunohistochemical analysis was performed on 32
pairs of parafﬁn-embedded cancer and adjacent normal tissues frompa-
tients with medical records. As shown in Table 1, RPL34 positive stain-
ing was 40.63% (13/32) in lung cancer tissues and 3.13% (1/32) in
adjacent non-cancerous tissues, p b 0.001. Representative immunohis-
tochemical staining results were shown in Fig. 1B (magniﬁcation:
200) and Fig. 1C (magniﬁcation: 400). The results showed that expres-
sion of RPL34 in cancer tissues was much higher than adjacent normal
tissues, while there was no signiﬁcant difference in the expression of
other control ribosomal proteins (data not shown). Thus, the elevation
of RPL34 expression may play an important role in the pathogenesis of
human NSCLC.
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of RPL34in mRNA and protein level
In order to study the role of RPL34 in NSCLC, lentivirus-mediated
shRNA of RPL34 in H1299 was conducted. RPL34 shRNA and control
shRNA lentiviruswere constructed. The infection efﬁciency of lentivirus
wasmonitored by detection of GFP expression after 3 days of transduc-
tion. As shown in Fig. 2A, over 90% of the cells were infected. qPCR and
Western blot were used to analyze the knockdown efﬁciency of RPL34
in H1299 cells. As shown in Fig. 2B, RPL34 mRNA level was reduced by
about 90% following RPL34 shRNA lentivirus as compared to control
group (p b 0.001). RPL34 protein level was also signiﬁcantly decreased
by shRNA lentivirus treatment (Fig. 2C). Expression of RPL34 in RPL34
shRNA group is about 45% of that in control group. The results showed
that lentivirus-mediated shRNA silencing speciﬁcally inhibits the ex-
pression of RPL34 in mRNA and protein level.
3.3. Inhibition of RPL34 signiﬁcantly suppresses growth of NSCLC cells
in vitro
To study the effect of RPL34 down-regulation on cell proliferation,
cell growth was measured via multiparametric high content screening
(HCS) at different times after RPL34 shRNA lentivirus infection. As
shown in Fig. 3B, proliferation of H1299 was signiﬁcantly inhibited
when RPL34 was down-regulated. The same result was also observed
in MTT assay, as shown in Fig. 3C.
To study the long-term effect of RPL34 shRNA lentivirus on cell
growth, we studied the colony formation capacity of H1299 cell line
with lentivirus treatment. After 72 h of lentivirus infection, cells were
allowed to grow for 14 days to form colonies (Fig. 4). The number ofFig. 5. Knockdown of RPL34 induced moderate S phase arrest in H1299.The proportion of diffe
Control and RPL34 shRNA: lentivirus transfection of nonsense shRNA and RPL34 shRNA. ** Sigcolonies in RPL34 shRNA treated H1299 was 40 ± 3.8, which was strik-
ingly lower than control groupwith 84.4± 12.2 colonies (p b 0.05). The
results revealed that down-regulation of RPL34 signiﬁcantly decreased
proliferation and colony formation of NSCLC cells in vitro.3.4. Inhibition of RPL34 moderately induced S phase arrest in NSCLC cells
in vitro
To study the impact of Lv-shRPL34-mediated knockdown of RPL34
on cell cycle of NSCLC cells, H1299 cells were subjected to ﬂow cytom-
etry assay 7 days after infection. The proportion of different cell cycle
phases was quantitated by PI staining followed by ﬂow cytometry
analyses. As shown in Fig. 5, cells in RPL34 shRNA groups displayed
more proportion in S phase compared to that in the control groups
(47.9% to 38.9%, p b 0.01). The result indicated that RPL34 may have
some impact on cell cycle, but the impact was moderate.3.5. Inhibition of RPL34 moderately increases apoptosis of NSCLC cells
in vitro
To study the effect of RPL34 knockdown in NSCLC cells, Annexin V
staining and ﬂow cytometry were carried out. As shown in Fig. 6A and
Fig. 6B, cell apoptosis rate in RPL34 shRNA group was about 1.46 times
to that in control group. RPL34 knockdownmoderately but signiﬁcantly
increases apoptosis of H1299, which indicated that RPL34 plays an im-
portant role in H1299. In consistence with the observation, the expres-
sion of Bcl-2 in H1299 infected with shRPL34 lentivirus was decreased
(shown in Fig. 6C).rent cell cycle phases was quantitated by PI staining followed by ﬂow cytometry analyses.
niﬁcant difference from control groups (p b 0.01).
Fig. 6. Down-regulation of RPL34 increases apoptosis of NSCLC cells H1299 in vitro. (A) Cell death was determined by annexin V staining and ﬂow cytometry. (B) RPL34 shRNA cultures
showed a moderate but signiﬁcant increase in apoptosis compared with control. (C) Expression of Bcl-2 protein in H1299 was detected withWestern blot in H1299 treated with control
shRNA and RPL34 shRNA. The relative expression level of RPL34was shown in theﬁgure,whichwasdetected by gray value analysis of thewestern-blot strips. ** Signiﬁcant difference from
control groups (p b 0.01).
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The function of ribosome in tumor cells was regulated abnormally
(Belin et al., 2009). For example, the transcription of rRNA was up-
regulated by oncogene MAPK/ERK and MYC, and down regulated by
tumor suppressor genes pRB and p53 (Belin et al., 2009). Besides the ab-
errant regulation of ribosome function in cancers, the outside-ribosome
function of ribosomal proteins was also involved in the development
and progress of some cancers (Khalaileh et al., 2013; Donati et al.,
2011). Therefore, it's not surprising to ﬁnd ribosomal protein RPL34
involved in cancer development and progression.
RPL34 was a rarely-reported ribosomal protein. So far, there is no
report on the role of RPL34 in cancers. In the present study, we found
that ribosomal protein L34 (RPL34) was highly expressed in clinical
non-small cell lung cancer (NSCLC) sections compared to sections of ad-
jacent tissues. The result led us to think that the over expression of ribo-
somal proteins was to meet the urgent need of protein synthesis by
NSCLC that is in rapid proliferation. But after checking the expression
of other ribosomal protein, we found that there is not an overall
elevating expression of ribosomal proteins, because we found that the
expression of other ribosomal proteins was not signiﬁcantly higherthan adjacent tissue. In order to study the function of RPL34 in NSCLC,
we conducted a lentivirusmediated shRNA of RPL34 in H1299 cell lines.
When RPL34was knocked down by RNAi, there was a strong impact
on cell proliferation and colony formation of H1299, which means that
RPL34 is very important for the growth of NSCLC cancer. We also
found that apoptosis of H1299 was signiﬁcantly increased when
RPL34 was knocked down though the impact was relatively moderate
compared to that on cell proliferation. Minor but signiﬁcant S phase ar-
rest was also observed in cell cycle test on H1299 after RPL34 knock-
down. In conclusion, over-expressed RPL34 may mainly increase cell
proliferation and therefore plays an important role in the development
and/or progression of NSCLC. RPL34 was also involved in the apoptosis-
resistance and cell cycle in NSCLC in some way.
RPL34 is a conserved ribosomal protein from Archaea to eukaryotes.
The protein folding pattern of RPL34 is different frommost of the other
ribosomal proteins. There is a zinc ﬁnger motif binding a zinc ion in
RPL34 (Klinge et al., 2011), which suggests the distinction of RPL34. Be-
sides the role as a ribosome-constituting protein, RPL34was reported to
be involved in other cell functions in prokaryotes, plant and animal cells.
We have a hypothesis that NSCLCmay take advantage of the distinctive
feature and “conserved” cell functions outside of ribosome of RPL34 to
428 S. Yang et al. / Gene 576 (2016) 421–428promote cell growth and apoptosis-resistance, thus playing an impor-
tant role in the development and progress of NSCLC. RPL34 may be a
good molecular diagnostic target and prognosis biomarker for NSCLC.
But more studies are needed to reveal the detailed mechanism in the
following study.
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